According to Zhenghai Biotech, on April 20, a national multi-center clinical trial summary meeting on calcium-silicon bioceramic bone repair materials was successfully held at Zhenghai Biotech. The conference revealed the key data results of the national multi-center randomized controlled clinical trial. The results showed that calcium-silicon bioceramic bone repair materials are used to fill and repair dental and jaw defects (or insufficient bone mass), and the curative effect is superior to imported comparison products. In terms of safety, the safety performance of the test product and the imported control product was similar.